A multi-cohort open-label study to assess clinical outcomes from an open label study of edivoxetine in pediatric patients with attention-deficit/hyperactivity disorder (ADHD).
Phase of Trial: Phase IV
Latest Information Update: 27 Nov 2015
At a glance
- Drugs Edivoxetine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- 27 Nov 2015 New trial record